We are live on ! Find out more
AG

Artal Group Portfolio holdings

AUM $1.01B
1-Year Est. Return 29.84%
This Fund
S&P 500
This Quarter Est. Return
+8.34%
1 Year Est. Return
+29.84%
3 Year Est. Return
+144%
5 Year Est. Return
+76.57%
10 Year Est. Return
+1,417.6%
AUM
$2.32B
AUM Growth
+$160M
Cap. Flow
+$106M
Cap. Flow %
4.55%
Top 10 Hldgs %
55.17%
Holding
93
New
22
Increased
20
Reduced
17
Closed
23

Sector Composition

Rank Sector Weight
1 Healthcare 34.21%
2 Consumer Discretionary 10.58%
3 Financials 3.02%
4 Industrials 2.27%
5 Communication Services 1.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LXRX icon
1
Lexicon Pharmaceuticals
LXRX
$1.03B
$463M 19.93%
57,517,978
-3
-0% -$22
WW
2
DELISTED
WW International
WW
$143M 6.15%
29,443,300
BIIB icon
3
CALL
Biogen
BIIB
$32B
$141M 6.09%
350,000
+115,000
+49% +$46.2M
WMT icon
4
CALL
Walmart Inc
WMT
$902B
$118M 5.08%
4,995,000
+4,095,000
+455% +$104M
GOOG icon
5
CALL
Alphabet (Google) Class C
GOOG
$4.05T
$117M 5.04%
+4,500,000
New +$121M
CELG
6
CALL
DELISTED
Celgene Corp
CELG
$69.4M 2.99%
600,000
+300,000
+100% +$34.3M
GS icon
7
CALL
Goldman Sachs
GS
$293B
$62.6M 2.7%
300,000
+200,000
+200% +$40.8M
BMRN icon
8
BioMarin Pharmaceuticals
BMRN
$12B
$59.5M 2.56%
435,000
-45,000
-9% -$5.58M
ALNY icon
9
Alnylam Pharmaceuticals
ALNY
$38.4B
$54.5M 2.35%
455,000
-15,000
-3% -$1.79M
GE icon
10
CALL
GE Aerospace
GE
$369B
$53.1M 2.29%
417,324
+208,662
+100% +$27.1M
INCY icon
11
Incyte
INCY
$25.6B
$50M 2.15%
480,000
-30,000
-6% -$3.11M
YUM icon
12
CALL
Yum! Brands
YUM
$42.2B
$45M 1.94%
695,500
-278,200
-29% -$17.6M
BAC icon
13
CALL
Bank of America
BAC
$434B
$42.5M 1.83%
2,500,000
-2,500,000
-50% -$41.2M
BABA icon
14
Alibaba
BABA
$275B
$41.1M 1.77%
500,000
-75,000
-13% -$6.45M
JPM icon
15
CALL
JPMorgan Chase
JPM
$930B
$40.7M 1.75%
600,000
-300,000
-33% -$19.6M
MA icon
16
Mastercard
MA
$497B
$37.4M 1.61%
400,000
+50,000
+14% +$4.59M
AXP icon
17
CALL
American Express
AXP
$225B
$35M 1.51%
+450,000
New +$35.7M
BLUE
18
DELISTED
bluebird bio
BLUE
$33.7M 1.45%
15,440
-11,580
-43% -$23.6M
MET icon
19
CALL
MetLife
MET
$62.5B
$33.6M 1.45%
673,200
-561,000
-45% -$26.6M
GM icon
20
CALL
General Motors
GM
$82.5B
$33.3M 1.43%
+1,000,000
New +$35.7M
QCOM icon
21
CALL
Qualcomm
QCOM
$169B
$31.3M 1.35%
+500,000
New +$34.1M
MS icon
22
CALL
Morgan Stanley
MS
$323B
$29.1M 1.25%
+750,000
New +$28.5M
MRK icon
23
CALL
Merck
MRK
$324B
$28.5M 1.23%
524,000
-1,257,600
-71% -$70.5M
AMZN icon
24
Amazon
AMZN
$2.45T
$28.2M 1.21%
1,300,000
+300,000
+30% +$6.27M
BMRN icon
25
CALL
BioMarin Pharmaceuticals
BMRN
$12B
$27.4M 1.18%
200,000

Similar funds

Artal Group's Q2 2015 Portfolio in Review

As of Q2 2015, Artal Group held 93 positions worth $2.32B, up 7.4% from $2.16B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Artal Group deployed $106M of net new capital in Q2 2015, opening 22 new positions and adding to 20 existing holdings. Its largest new stake was American Airlines Group: 400,000 shares worth $16M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was bluebird bio, an estimated $23.6M trimmed.

  • Artal Group's largest Q2 2015 buy was American Airlines Group: 400,000 shares worth $16M.
  • Artal Group added most to Happen Inc in Q2 2015, an estimated $10.3M increase.
  • Artal Group's biggest Q2 2015 reduction was bluebird bio, cutting an estimated $23.6M.
  • Artal Group fully exited Alphabet (Google) Class C in Q2 2015, selling an estimated $48.4M.
  • Artal Group's ten largest holdings make up 55% of its $2.32B portfolio in Q2 2015.
  • Artal Group opened 22 new positions and closed 23 in Q2 2015.
  • Artal Group's portfolio value rose 7.4% quarter-over-quarter to $2.32B.

Based on Artal Group's 13F filing for Q2 2015, filed 13 Aug 2015.